Valuation: DocMorris AG

Market Cap 497M 615M 537M 459M 864M 59.06B 880M 5.92B 2.32B 28.92B 2.31B 2.26B 99.58B P/E 2026 *
-6.45x
P/E 2027 * -12.1x
Enterprise Value 698M 864M 755M 645M 1.21B 82.98B 1.24B 8.32B 3.27B 40.63B 3.25B 3.17B 140B EV / Sales 2026 *
0.57x
EV / Sales 2027 * 0.53x
Free-Float
66.58%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 61 27/04/2022
Director of Finance/CFO 56 30/09/2024
Chief Tech/Sci/R&D Officer - 31/10/2024
Director TitleAgeSince
Chairman 68 27/04/2022
Director/Board Member 53 22/05/2019
Director/Board Member 56 31/12/2020
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 605M
-1.41%-1.98%-19.34%-29.45% 14.96B
-1.21%-6.03%-28.45%-34.60% 6.91B
-0.27%-3.26%-21.49%-7.69% 5.9B
+3.14%+5.85%-12.10%-30.29% 3.7B
-0.59%-7.44%-38.67%-15.23% 3.13B
-0.81%-2.97%-29.84%-47.92% 3.19B
+8.85%+12.59%+13.36%-27.51% 3.04B
-1.54%-0.75%+94.56% - 2.55B
0.00%-3.75%-20.63%-3.23% 2.46B
Average +0.68%+0.27%-6.96%-24.49% 5.09B
Weighted average by Cap. +0.15%-0.53%-14.02%-26.08%

Financials

2026 *2027 *
Net sales 1.23B 1.52B 1.33B 1.13B 2.13B 146B 2.17B 14.61B 5.73B 71.32B 5.7B 5.57B 246B 1.38B 1.7B 1.49B 1.27B 2.39B 164B 2.44B 16.4B 6.44B 80.09B 6.4B 6.25B 276B
Net income -84.01M -104M -90.87M -77.61M -146M -9.99B -149M -1B -393M -4.89B -391M -382M -16.84B -46.25M -57.25M -50.03M -42.73M -80.47M -5.5B -81.92M -552M -216M -2.69B -215M -210M -9.27B
Net Debt 201M 249M 218M 186M 350M 23.93B 356M 2.4B 942M 11.72B 936M 915M 40.34B 237M 293M 256M 219M 412M 28.14B 419M 2.82B 1.11B 13.78B 1.1B 1.08B 47.45B
Logo DocMorris AG
DocMorris AG, formerly Zur Rose Group AG, is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. DocMorris operates at the healthcare, technology and e-commerce, with a primary focus on customer-centric digital healthcare and improving medication efficacy. core business is online pharmacy. In addition to prescription medicines (Rx), assortment features over-the-counter (OTC) and consumer health as well as beauty and personal care (BPC) products. Private labels, including nutritional supplements, painkillers, first-aid products and other OTC medicines. The Company's operates under brands such as PromoFarma, DoctiPharma, Apotal, Medpex and Teleclinic, among others
Employees
-
Trader
Investor
-
Global
-
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
10.16CHF
Average target price
8.506CHF
Spread / Average Target
-16.28%

Quarterly revenue - Rate of surprise